Trademark: 97043465
Status Date
Monday, January 22, 2024
Filing Date
Friday, September 24, 2021
Published for Opposition
Tuesday, June 27, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
Jan 24, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 22, 2024
Sou Extension 1 Granted
Jan 22, 2024
Sou Extension 1 Filed
Jan 22, 2024
Sou Teas Extension Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 25, 2023
Approved For Pub - Principal Register
Nov 22, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 22, 2022
Letter Of Suspension E-Mailed
Nov 22, 2022
Suspension Letter Written
Nov 18, 2022
Teas/Email Correspondence Entered
Nov 17, 2022
Correspondence Received In Law Office
Nov 17, 2022
Teas Response To Office Action Received
Jun 6, 2022
Notification Of Non-Final Action E-Mailed
Jun 6, 2022
Non-Final Action E-Mailed
Jun 6, 2022
Non-Final Action Written
Jun 5, 2022
Assigned To Examiner
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2021
New Application Office Supplied Data Entered
Sep 28, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24